Perioperative dexketoprofen or lornoxicam administration for pain management after major orthopedic surgery: a randomized, controlled study

Amaç: Non-steroidal antienflamatuvar ilaçlar (NSAİİ) multimodal ameliyat sonrası ağrı tedavisinde kullanılması önerilen ilaçlar- dır. Bu çalışmanın amacı majör ortopedik cerrahi sonrasında kullanılan deksketoprofen ve lornoksikamın ameliyat sonrası analjezik etkinliğini ve morfin tüketiminde yaptığı azalmayı incelemektir. Gereç ve Yöntem: Etik kurul izni ve hasta onamı alındıktan sonra genel anestezi altında elektif kalça veya diz total protezi uygula- nacak 120 hasta iki doz 50 mg deksketoprofen (GD), iki doz 8 mg lornoksikam (GL) veya plasebo (GP) alacak şekilde randomize edildi. Ameliyat sonrası dönemde, 0.01 mg.kg-1 bolus doz ve kilitli kalma 10 dak olacak şekilde morfin içeren HKA bazal infüzyon olmadan başlandı. Ağrı değerlendirmesi ameliyat sonrası 1, 2, 4, 6, 8, 12 ve 24. saatlerde istirahat ve hareket halinde VAS ile yapıldı. Bulgular: Gruplar arasında yaş, cinsiyet, ASA değeri, kalça ve diz protezi yapılan hasta sayısı, ağırlık, boy ve operasyon süresi açısından fark yoktu. GD ve GL hastalarının istirahat ve aktif hareket halindeki VAS değerleri GPdeki hastalardan anlamlı olarak daha düşüktü. GDnin istirahat ve aktif hareket halindeki VAS değerleri GLden daha düşük olarak bulundu. GD ve GLdeki has- taların ameliyat sonrası morfin tüketimi GPdekilerden anlamlı olarak daha düşüktü. GDdeki hastaların toplam morfin tüketimi GLden daha düşük bulundu. Sonuç: Elli mg deksketoprofenin ve 8 mg lornoksikamın intravenöz yoldan günde iki doz uygulanmasının majör ortopedik cerrahi sonrası plaseboya göre daha iyi analjezi sağladığı ve morfin tüketimini azalttığı bulundu. İki aktif ilaç karşılaştırıldığında ise analjezik etkinlik ve morfin tüketimi açısından deksketoprofen lornoksikamdan daha üstün bulundu.

Majör ortopedik cerrahi sonrası ağrı tedavisinde deksketoprofen veya lornoksikam kullanımı: Randomize ve kontrollü bir çalışma

Objective: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for multimodal postoperative pain manage- ment. The purpose of this study was to evaluate the postoperative pain relief and opioid-sparing effects of dexketoprofen and lornoxicam after major orthopedic surgery. Methods: After obtaining ethical committee approval and informed consent, 120 patients undergoing elective hip or knee replacement under general anesthesia were randomized to receive two intravenous injections of 50 mg dexketoprofen (GD), 8 mg lornoxicam (GL) or saline as placebo (GP) intravenously. Postoperatively, patient-controlled analgesia (PCA) morphine was started as a 0.01 mg.kg-1 bolus dose, with lockout time of 10 minutes without continuous infusion. Pain assessment was made using the Visual Analogue Scale (VAS) at rest or during movement at postoperative 1, 2, 4, 6, 8, 12, and 24 hours. Results: The three groups were similar in terms of age, gender, American Society of Anesthesiologists (ASA) class, number of patients who underwent hip or knee surgery, weight, height, and operation duration. Patients in GD and GL demonstrated sig- nificantly reduced pain scores at rest and active motion compared to GP, with lower scores in the dexketoprofen group. Patients in GD and GL used significantly less morphine in the postoperative period compared to GP. The total morphine consumption of patients in GD was lower than in GL. Conclusion: Intravenous application of 50 mg dexketoprofen twice a day and 8 mg lornoxicam twice a day improved analgesia and decreased morphine consumption following major orthopedic surgery. When the two active drugs were compared, it was found that dexketoprofen was superior to lornoxicam in terms of analgesic efficacy and opioid consumption.

___

  • 1. White PF. The changing role of non-opioid analgesic tech- niques in the management of postoperative pain. Anesth Analg 2005;101(5 Suppl):5-22.
  • 2. Andersen LØ, Husted H, Otte KS, Kristensen BB, Kehlet H. High-volume infiltration analgesia in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand 2008;52(10):1331-5.
  • 3. Elia N, Lysakowski C, Tramèr MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-con- trolled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 2005;103(6):1296-304.
  • 4. Hanna MH, Elliott KM, Stuart-Taylor ME, Roberts DR, Buggy D, Arthurs GJ. Comparative study of analgesic efficacy and morphine-sparing effect of intramuscular dexketoprofen trometamol with ketoprofen or placebo after major ortho- paedic surgery. Br J Clin Pharmacol 2003;55(2):126-33.
  • 5. Karaman S, Gunusen I, Uyar M, Firat V. The effect of pre-op- erative lornoxicam and ketoprofen application on the mor- phine consumption of post-operative patient-controlled analgesia. J Int Med Res 2006;34(2):168-75.
  • 6. Yazar MA, Inan N, Ceyhan A, Sut E, Dikmen B. Postoperative analgesic efficacy of intravenous dexketoprofen in lumbar disc surgery. J Neurosurg Anesthesiol 2011;23(3):193-7.
  • 7. Mauleón D, Artigas R, García ML, Carganico G. Preclinical and clinical development of dexketoprofen. Drugs 1996;52 Suppl 5:24-46.
  • 8. Moore RA, Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol 2008;8:11.
  • 9. Radhofer-Welte S, Rabasseda X. Lornoxicam, a new potent NSAID with an improved tolerability profile. Drugs Today (Barc) 2000;36(1):55-76.
  • 10. Paulus HE. Nonsteroidal anti-inflammatory drugs. In: Kelly WN, editor. Textbook of rheumatology. Philadelphia: W.B. Saunders; 1989. p. 776.
  • 11. Schug SA, Merry AF, Acland RH. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 1991;42(2):228-39.
  • 12. Nuutinen LS, Laitinen JO, Salomäki TE. A risk-benefit apprais- al of injectable NSAIDs in the management of postoperative pain. Drug Saf 1993;9(5):380-93.
  • 13. Tuncer S, Pirbudak L, Balat O, Capar M. Adding ketoprofen to intravenous patient-controlled analgesia with tramadol after major gynecological cancer surgery: a double-blinded, randomized, placebo-controlled clinical trial. Eur J Gynaecol Oncol 2003;24(2):181-4.
  • 14. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg 1993;77(5):1048-56.
  • 15. Barbanoj MJ, Antonijoan RM, Gich I. Clinical pharmacokinet- ics of dexketoprofen. Clin Pharmacokinet 2001;40(4):245-62.
  • 16. Zippel H, Wagenitz A. Comparison of the efficacy and safety of intravenously administered dexketoprofen trometamol and ketoprofen in the management of pain after orthopae- dic surgery: A multicentre, double-blind, randomised, paral- lel-group clinical trial. Clin Drug Investig 2006;26(9):517-28.
  • 17. Iohom G, Walsh M, Higgins G, Shorten G. Effect of periop- erative administration of dexketoprofen on opioid require- ments and inflammatory response following elective hip arthroplasty. Br J Anaesth 2002;88(4):520-6.
  • 18. Rosenow DE, Albrechtsen M, Stolke D. A comparison of pa- tient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth Analg 1998;86(5):1045-50.
  • 19. Korkmaz Dilmen O, Tunali Y, Cakmakkaya OS, Yentur E, Tu- tuncu AC, Tureci E, et al. Efficacy of intravenous paracetamol, metamizol and lornoxicam on postoperative pain and mor- phine consumption after lumbar disc surgery. Eur J Anaes- thesiol 2010;27(5):428-32.
  • 20. Inan N, Ozcan N, Takmaz SA, Ozcan A, Erdoğan I, Baltaci B. Efficacy of lornoxicam in postoperative analgesia after total knee replacement surgery. Agri 2007;19(2):38-45.
  • 21. Berti M, Albertin A, Casati A, Palmisano S, Municino G, da Gama Malcher M, et al. A prospective, randomized com- parison of dexketoprofen, ketoprofen or paracetamol for postoperative analgesia after outpatient knee arthroscopy. Minerva Anestesiol 2000;66(7-8):549-54.
  • 22. Leman P, Kapadia Y, Herington J. Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and di- clofenac in lower limb injury. Emerg Med J 2003;20(6):511-3.
Ağrı-Cover
  • ISSN: 1300-0012
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2018
  • Yayıncı: Ali Cangül
Sayıdaki Diğer Makaleler

Yüksek riskli mastektomi olgusunda torasik epidural anestezi-interskalen blok kombinasyonunun uygulanması: Olgu sunumu

Abdulkadir YEKTAŞ, Güneş Ülkü ÜLGER, Mevlüt ÇÖMLEKÇİ, Hacer YETER, Funda GÜMÜŞ, Kerem ERKALP, Ayşin ALAGÖL

The effectiveness of subcutaneously implanted epidural ports for relief of severe pain in patients with advanced-stage gynecological cancer: a prospective study

İbrahim Egemen ERTAŞ, Salim ŞEHİRALİ, Serpil ÖCEL ÖZSEZGİN, Muzaffer SANCI, Gülderen ARBAK, Yusuf YILDIRIM

Ultrasound-guided psoas compartment block and general anesthesia for arthroscopic knee surgery: a case report

EMİNE AYSU ŞALVIZ, Yavuz GÜRKAN, Murat TEKİN, Levent BULUÇ

Use of complementary and alternative medicine by a sample of Turkish primary headache patients

Başak GÖKSEL KARAKUM, ÖZLEM COŞKUN, Serap ÜÇLER, Mehmet KARATAŞ, Aynur ÖZGE, SEÇİL ÖZKAN

Systemic toxicity to local anesthesia in an infant undergoing circumcision

Ayşe Belin ÖZER, Ömer Lütfi ERHAN

Perioperative dexketoprofen or lornoxicam administration for pain management after major orthopedic surgery: a randomized, controlled study

Nükhet SİVRİKOZ, AHMET KEMALETTİN KOLTKA, Ece GÜREŞTİ, Mehmet BÜGET, NÜZHET MERT ŞENTÜRK, Süleyman ÖZYALÇIN

Günübirlik operatif histeroskopi sonrası intravenöz parasetamol ve deksketoprofen trometamol\'ün analjezik etkinliklerinin karşılaştırılması: Randomize, çift kör, plasebo kontrollü çalışma

Aysu KOÇUM, MESUT ŞENER, Hatice İZMİRLİ, Bülent HAYDARDEDEOĞLU, Anış ARIBOĞAN

Preemptive analgesic efficacy of dexketoprofen trometamol on impacted third molar surgery

Esra ÇAĞIRAN, CAN EYİGÖR, Bahar SEZER, Meltem UYAR